Clinical Trial: Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100
Study Status: Completed
Recruit Status: RECRUITING
Condition: Ovarian Clear Cell Carcinoma
Study Type: INTERVENTIONAL
Official Title: Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100
Brief Summary:
To learn if the combination of dostarlimab and LB-100 can help to control ovarian clear cell carcinoma
Read more